Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKDC | P78527 | 4/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 2/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21914467 | 0.90 | ALOX5 (0.38) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL21914282 | 0.89 | PRKDC (0.36) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL21915065 | 0.88 | PARP14 (0.39) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL21915080 | 0.87 | PARP14 (0.33) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL21914486 | 0.87 | PRKDC (0.35) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL21914729 | 0.87 | PRKDC (0.35) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL21914487 | 0.86 | PRKDC (0.35) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL21914264 | 0.85 | PRKDC (0.40) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL21914292 | 0.83 | KDM4E (0.37) | PRKDCPIK3CDPIK3CBBRD4PIK3CA | |
| SCHEMBL21915075 | 0.83 | ALOX5 (0.37) | PRKDCPIK3CDPIK3CB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11873311-B2 | Heterocyclic compound, organic electroluminescent device, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| US-11873311-B2 | Heterocyclic compound, organic electroluminescent device, and electronic device | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2024-01-16 | — | — | US | disclosed |
| US-20230312604-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
| US-20230312604-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-10-05 | — | — | US | disclosed |
| WO-2021136277-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC DEVICE | 陕西莱特光电材料股份有限公司 | 2021-07-08 | — | — | WO | disclosed |
| US-20200127214-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | LG DISPLAY CO., LTD. (KR) | 2020-04-23 | — | — | US | disclosed |
| US-20200119299-A1 | ORGANIC LIGHT-EMITTING DIODE AND ORGANIC LIGHT-EMITTING DEVICE HAVING THE SAME | LG DISPLAY CO., LTD (KR) | 2020-04-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200127214-A1 | ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE HAVING THE SAME | MAP1LC3A, MAP1LC3C, MAP1LC3B | PRKDC 3055/4885PIK3CD 2856/4885PIK3CB 3862/4885 |
| US-20230312604-A1 | HETEROCYCLIC COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC DEVICE | ODC1, LEF1, PIEZO1 | PRKDC 4555/4885PIK3CD 3906/4885PIK3CB 4368/4885 |
| US-11873311-B2 | Heterocyclic compound, organic electroluminescent device, and electronic device | ODC1, LEF1, PIEZO1 | PRKDC 4555/4885PIK3CD 3906/4885PIK3CB 4368/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.